CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Sam Craft

OPENALEX: A5091597544↗ORCID: 0000-0002-5663-2731↗

Affiliations

Organizations

Institute of Mental Healthauthorship · GB King's College Londonauthorship · GB National Drug Addiction Centerauthorship · BG University of Bathauthorship · GB

Public evidence

4 connected articles

Applying machine learning to international drug monitoring: classifying cannabis resin collected in Europe using cannabinoid concentrations.2025 · Europe PMC Commentary on Allaf et al.: Comparing countries with different legal cannabis markets can inform on the impact of regulating product type and potency.2023 · Europe PMC Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis.2022 · Europe PMC Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act.2022 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Sam Craft - Medical Cannabis Research Engine